About Jennifer Ahlstrom
Articles by Jennifer Ahlstrom
Blood Glucose, MGUS, Metformin and Myeloma: Part 2Feb 02, 2018
Family Genetic Mutations Linked to Multiple Myeloma RiskFeb 01, 2018
Clinical Trial: Further Insight on INSIGHT Myeloma Observational Clinical TrialJan 31, 2018
Using Light To Eliminate Multiple Myeloma at Washington UniversityJan 25, 2018
The Role of the Bone Marrow Environment in MGUS or Smoldering Myeloma ProgressionJan 25, 2018
Celgene To Acquire Juno Therapeutics for CAR T Cell Myeloma TherapiesJan 22, 2018
My Myeloma and CAR T Cell Experience, by Daniel RiebowJan 22, 2018
Clinical Trial: Natural Killer Cells Clinical Trial in Phase I for Relapsed and Refractory Multiple Myeloma PatientsJan 18, 2018
Staying On Myeloma Maintenance Therapy - How Long and Which Drug(s)?Jan 15, 2018
How Immunomodulators Work in Multiple MyelomaJan 11, 2018
C-Reactive Protein (Inflammation) Levels Before Transplant Can Indicate Overall Myeloma SurvivalJan 09, 2018
FDA Approves Denosumab Bone Strengthener for Myeloma PatientsJan 05, 2018
Janssen Oncology Jumps Into Myeloma BCMA CAR T Field in Collaboration With Chinese Firm Legend BioDec 22, 2017
ASH 2017: Myeloma, Bloodclots and AspirinDec 15, 2017
ASH 2017: Second Line Therapy to Deepen Responses Before Transplant Provides Worse Outcomes Than Just Going to Transplant ImmediatelyDec 13, 2017
ASH 2017: Myeloma Patients Need a Flu Shot Booster!Dec 10, 2017
La deficiencia de vitamina D antes del trasplante puede aumentar el riesgo de recaída del mielomaDec 06, 2017
La falta de sueño y sus efectos sobre el cáncerDec 06, 2017
Adaptive's Next Generation Sequencing Tool Used in Myeloma Clinical Trial to Track Minimal Residual Disease StatusNov 28, 2017
Mayo Clinic Shows Myeloma Expertise Matters for Long Term OutcomesNov 22, 2017
Clinical Trial: Comparing Oral Myeloma Medications (ixazomib/dex vs. pomalidomide/dex)Nov 18, 2017
Understanding the Myeloma Stem Cell Transplant ProcessNov 18, 2017
New Bone Strengthener Shows Greater Anti-Myeloma Effect and ConvenienceNov 14, 2017
Clinical Trial: KITE Pharma's CAR T Cell Trial for Relapsed/Refractory MyelomaOct 27, 2017